1692 related articles for article (PubMed ID: 23763360)
1. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
3. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
4. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
[TBL] [Abstract][Full Text] [Related]
5. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.
Kruger FC; Daniels CR; Kidd M; Swart G; Brundyn K; van Rensburg C; Kotze M
S Afr Med J; 2011 Jun; 101(7):477-80. PubMed ID: 21920102
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
8. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
Francque SM; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
11. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.
Demir M; Lang S; Nierhoff D; Drebber U; Hardt A; Wedemeyer I; Schulte S; Quasdorff M; Goeser T; Töx U; Steffen HM
J Clin Gastroenterol; 2013 Sep; 47(8):719-26. PubMed ID: 23442837
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
[TBL] [Abstract][Full Text] [Related]
13. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
[TBL] [Abstract][Full Text] [Related]
14. The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease.
Fierbinteanu-Braticevici C; Plesca DA; Tribus L; Panaitescu E; Braticevici B
J Gastrointestin Liver Dis; 2013 Jun; 22(2):149-56. PubMed ID: 23799213
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
Amarapurkar DN; Patel ND
Trop Gastroenterol; 2004; 25(3):130-4. PubMed ID: 15682660
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
17. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
[TBL] [Abstract][Full Text] [Related]
18. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
Tasneem AA; Luck NH; Majid Z
Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
